Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
100%
Proton Pump Inhibitors
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Severe Outcomes
36%
Infection Risk
27%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
27%
95% Confidence Interval
27%
Hospital Admission
18%
COVID-19
18%
Denmark
9%
Relative Risk
9%
Adjusted Odds Ratio
9%
Mortality Risk
9%
Confounding
9%
Infectious Diseases
9%
Intensive Care Unit Admission
9%
Residual Confounding
9%
Mechanical Ventilation
9%
Propensity Score Matching
9%
Nationwide Observational Study
9%
Pooled Odds Ratios
9%
COVID-19 Pandemic
9%
Case-Control Design
9%
Adjusted Relative Risk
9%
Infection Outcomes
9%
Medicine and Dentistry
Meta-Analysis
100%
Proton-Pump Inhibitor
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
54%
COVID-19
27%
Odds Ratio
18%
Intensive Care Unit
9%
Observational Study
9%
Artificial Respiration
9%
Design Controls
9%
Propensity Score Matching
9%
Pharmacology, Toxicology and Pharmaceutical Science
Proton Pump Inhibitor
100%
SARS Coronavirus
100%
Infection
54%
Coronavirinae
27%
Diseases
27%
Observational Study
9%